PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-60.51%
Negative net income growth while VET stands at 100.29%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
1.78%
Some D&A expansion while VET is negative at -84.35%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-47.06%
Negative yoy deferred tax while VET stands at 115.03%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
9.52%
SBC growth while VET is negative at -29.89%. John Neff would see competitor possibly controlling share issuance more tightly.
-408.26%
Both reduce yoy usage, with VET at -11173.43%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
104.76%
AR growth of 104.76% while VET is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-774.16%
Both reduce yoy usage, with VET at -11173.43%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
69.22%
Lower 'other non-cash' growth vs. VET's 11114.25%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-49.79%
Negative yoy CFO while VET is 3.04%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
5.65%
Some CapEx rise while VET is negative at -5726.60%. John Neff would see competitor possibly building capacity while we hold back expansions.
-378.04%
Both yoy lines negative, with VET at -102.55%. Martin Whitman sees an overall caution or integration phase for both companies’ expansions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
103.72%
We have some outflow growth while VET is negative at -97.17%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-5.08%
Both yoy lines negative, with VET at -36.42%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-1.20%
We cut debt repayment yoy while VET is 89.15%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
-371.70%
Both yoy lines negative, with VET at -26.70%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.